{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T04:14:06Z","timestamp":1729570446085,"version":"3.28.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,21]]},"DOI":"10.7759\/cureus.72026","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T14:21:28Z","timestamp":1729520488000},"source":"Crossref","is-referenced-by-count":0,"title":["Abdominal Hypertrophy Syndrome: Characteristics and Potential Pathophysiology"],"prefix":"10.7759","author":[{"given":"Igor A","family":"Suslin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iakov V","family":"Efimenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Castrellon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarik M","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90263-c","article-title":"Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone","volume":"104","author":"Ulshen M","year":"1993","unstructured":"Ulshen M, Dowling R, Fuller C, Zimmermann E, Lund P. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. Gastroenterology. 1993, 104:973-80. 10.1016\/0016-5085(93)90263-c","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1536-4801.1992.tb10482.x","article-title":"Effects of short-term growth hormone therapy in rats undergoing 75% small intestinal resection","volume":"14","author":"Shulman DI","year":"1992","unstructured":"Shulman DI, Hu CS, Duckett G, Lavallee-Grey M. Effects of short-term growth hormone therapy in rats undergoing 75% small intestinal resection. J Pediatr Gastroenterol Nutr. 1992, 14:3-11. 10.1002\/j.1536-4801.1992.tb10482.x","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90318-S","article-title":"Truncated and native insulinlike growth factor I enhance mucosal adaptation after jejunoileal resection","volume":"102","author":"Vanderhoof JA","year":"1992","unstructured":"Vanderhoof JA, McCusker RH, Clark R, Mohammadpour H, Blackwood DJ, Harty RF, Park JHY. Truncated and native insulinlike growth factor I enhance mucosal adaptation after jejunoileal resection. Gastroenterology. 1992, 102:1949-56. 10.1016\/0016-5085(92)90318-S","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao A","year":"2019","unstructured":"Colao A, Grasso LF, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R. Acromegaly. Nat Rev Dis Primers. 2019, 5:20. 10.1038\/s41572-019-0071-6","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) Database","volume":"24","author":"Petrossians P","year":"2017","unstructured":"Petrossians P, Daly AF, Natchev E, et al.. Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) Database. Endocr Relat Cancer. 2017, 24:505-18. 10.1530\/ERC-17-0253","journal-title":"Endocr Relat Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20018","article-title":"Acromegaly and the colon: scoping beyond the pituitary","volume":"13","author":"Patel GS","year":"2021","unstructured":"Patel GS, Grossmann I, Rodriguez K, et al.. Acromegaly and the colon: scoping beyond the pituitary. Cureus. 2021, 13:e20018. 10.7759\/cureus.20018","journal-title":"Cureus"},{"key":"ref7","article-title":"Increased epithelial cell proliferation in the colon of patients with acromegaly","volume":"1","author":"Cats A","year":"1996","unstructured":"Cats A, Dullaart RP, Kleibeuker JH, Kuipers F, Sluiter WJ, Hardonk MJ, de Vries EG. Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Research. 1996, 1:523-6.","journal-title":"Cancer Research"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-17","article-title":"Acromegaly","volume":"3","author":"Chanson P","year":"2008","unstructured":"Chanson P, Salenave S. Acromegaly. Orphanet J Rare Dis. 2008, 3:17. 10.1186\/1750-1172-3-17","journal-title":"Orphanet J Rare Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2016.1190690","article-title":"The sports psychiatrist and performance-enhancing drugs","volume":"28","author":"Creado S","year":"2016","unstructured":"Creado S, Reardon C. The sports psychiatrist and performance-enhancing drugs. Int Rev Psychiatry. 2016, 28:564-71. 10.1080\/09540261.2016.1190690","journal-title":"Int Rev Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/er.2013-1058","article-title":"Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement","volume":"35","author":"Pope HG Jr","year":"2014","unstructured":"Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014, 35:341-75. 10.1210\/er.2013-1058","journal-title":"Endocr Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/000992289203101206","article-title":"Human growth hormone: a new substance of abuse among adolescents?","volume":"31","author":"Rickert VI","year":"1992","unstructured":"Rickert VI, Pawlak-Morello C, Sheppard V, Jay MS. Human growth hormone: a new substance of abuse among adolescents?. Clin Pediatr (Phila). 1992, 31:723-6. 10.1177\/000992289203101206","journal-title":"Clin Pediatr (Phila)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2010.00093.x","article-title":"Human growth hormone abuse in male weightlifters","volume":"20","author":"Brennan BP","year":"2011","unstructured":"Brennan BP, Kanayama G, Hudson JI, Pope HG Jr. Human growth hormone abuse in male weightlifters. Am J Addict. 2011, 20:9-13. 10.1111\/j.1521-0391.2010.00093.x","journal-title":"Am J Addict"},{"key":"ref13","article-title":"Does central obesity reflect \"Cushing's disease of the omentum\"?","volume":"26","author":"Bujalska IJ","year":"1997","unstructured":"Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect \"Cushing's disease of the omentum\"?. Lancet. 1997, 26:1210-3.","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.03.008","article-title":"Exercise reinforcement, stress, and \u03b2-endorphins: an initial examination of exercise in anabolic-androgenic steroid dependence","volume":"139","author":"Hildebrandt T","year":"2014","unstructured":"Hildebrandt T, Shope S, Varangis E, Klein D, Pfaff DW, Yehuda R. Exercise reinforcement, stress, and \u03b2-endorphins: an initial examination of exercise in anabolic-androgenic steroid dependence. Drug Alcohol Depend. 2014, 139:86-92. 10.1016\/j.drugalcdep.2014.03.008","journal-title":"Drug Alcohol Depend"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199409000-00001","article-title":"Acromegaly. Clinical and biochemical features in 500 patients","volume":"73","author":"Ezzat S","year":"1994","unstructured":"Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG. Acromegaly. Clinical and biochemical features in 500 patients. Medicine. 1994, 73:233-40. 10.1097\/00005792-199409000-00001","journal-title":"Medicine"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.23.1.0457","article-title":"Turner's syndrome in adulthood","volume":"23","author":"Elsheikh M","year":"2002","unstructured":"Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner's syndrome in adulthood. Endocr Rev. 2002, 23:120-40. 10.1210\/edrv.23.1.0457","journal-title":"Endocr Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1988.tb15881.x","article-title":"Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984","volume":"223","author":"Bengtsson BA","year":"1988","unstructured":"Bengtsson BA, Ed\u00e9n S, Ernest I, Od\u00e9n A, Sj\u00f6gren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand. 1988, 223:327-35. 10.1111\/j.0954-6820.1988.tb15881.x","journal-title":"Acta Med Scand"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01218.x","article-title":"Growth hormone and the heart","volume":"54","author":"Colao A","year":"2001","unstructured":"Colao A, Marzullo P, Di Somma C, Lombardi G. Growth hormone and the heart. Clin Endocrinol (Oxf). 2001, 54:137-54. 10.1046\/j.1365-2265.2001.01218.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.19.1.437","article-title":"Transgenic models of growth hormone action","volume":"19","author":"Kopchick JJ","year":"1999","unstructured":"Kopchick JJ, Bellush LL, Coschigano KT. Transgenic models of growth hormone action. Annu Rev Nutr. 1999, 19:437-61. 10.1146\/annurev.nutr.19.1.437","journal-title":"Annu Rev Nutr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/19.5.270","article-title":"Cardiomegaly and haemodynamics in rats with a transplantable growth hormone-secreting tumour","volume":"19","author":"Penney DG","year":"1985","unstructured":"Penney DG, Dunbar JC Jr, Baylerian MS. Cardiomegaly and haemodynamics in rats with a transplantable growth hormone-secreting tumour. Cardiovasc Res. 1985, 19:270-7. 10.1093\/cvr\/19.5.270","journal-title":"Cardiovasc Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb02388.x","article-title":"Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations","volume":"39","author":"Cohn L","year":"1993","unstructured":"Cohn L, Feller AG, Draper MW, Rudman IW, Rudman D. Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations. Clin Endocrinol (Oxf). 1993, 39:417-25. 10.1111\/j.1365-2265.1993.tb02388.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/53a.3.m183","article-title":"Side effects resulting from the use of growth hormone and insulin-like growth factor-I as combined therapy to frail elderly patients","volume":"53","author":"Sullivan DH","year":"1998","unstructured":"Sullivan DH, Carter WJ, Warr WR, Williams LH. Side effects resulting from the use of growth hormone and insulin-like growth factor-I as combined therapy to frail elderly patients. J Gerontol A Biol Sci Med Sci. 1998, 53:M183-7. 10.1093\/gerona\/53a.3.m183","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/59.7.b652","article-title":"Use of growth hormone for prevention or treatment of effects of aging","volume":"59","author":"Harman SM","year":"2004","unstructured":"Harman SM, Blackman MR. Use of growth hormone for prevention or treatment of effects of aging. J Gerontol A Biol Sci Med Sci. 2004, 59:652-8. 10.1093\/gerona\/59.7.b652","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.4.3.311","article-title":"Mecasermin rinfabate: rhIGF-I\/rhIGFBP-3 complex: iPLEX","volume":"4","author":"Williams RM","year":"2008","unstructured":"Williams RM, McDonald A, O'Savage M, Dunger DB. Mecasermin rinfabate: rhIGF-I\/rhIGFBP-3 complex: iPLEX. Expert Opin Drug Metab Toxicol. 2008, 4:311-24. 10.1517\/17425255.4.3.311","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-199911010-00006","article-title":"Somatomedin-1 (recombinant insulin-like growth factor-1): clinical pharmacology and potential treatment of endocrine and metabolic disorders","volume":"11","author":"Laron Z","year":"1999","unstructured":"Laron Z. Somatomedin-1 (recombinant insulin-like growth factor-1): clinical pharmacology and potential treatment of endocrine and metabolic disorders. BioDrugs. 1999, 11:55-70. 10.2165\/00063030-199911010-00006","journal-title":"BioDrugs"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1378","article-title":"Insulin-like growth factor-I and cancer mortality in older men","volume":"95","author":"Major JM","year":"2010","unstructured":"Major JM, Laughlin GA, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Insulin-like growth factor-I and cancer mortality in older men. J Clin Endocrinol Metab. 2010, 95:1054-9. 10.1210\/jc.2009-1378","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3751-0","article-title":"Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis","volume":"59","author":"Abdulla H","year":"2016","unstructured":"Abdulla H, Smith K, Atherton PJ, Idris I. Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis. Diabetologia. 2016, 59:44-55. 10.1007\/s00125-015-3751-0","journal-title":"Diabetologia"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.2012.01123","article-title":"Psychological and physical impact of anabolic-androgenic steroid dependence","volume":"32","author":"Ip EJ","year":"2012","unstructured":"Ip EJ, Lu DH, Barnett MJ, Tenerowicz MJ, Vo JC, Perry PJ. Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy. 2012, 32:910-9. 10.1002\/j.1875-9114.2012.01123","journal-title":"Pharmacotherapy"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-015-0006-5","article-title":"Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis","volume":"10","author":"Sagoe D","year":"2015","unstructured":"Sagoe D, McVeigh J, Bj\u00f8rnebekk A, Essilfie MS, Andreassen CS, Pallesen S. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Subst Abuse Treat Prev Policy. 2015, 10:12. 10.1186\/s13011-015-0006-5","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-016-0056-3","article-title":"Recruitment to doping and help-seeking behavior of eight female AAS users","volume":"11","author":"B\u00f6rjesson A","year":"2016","unstructured":"B\u00f6rjesson A, G\u00e5revik N, Dahl ML, Rane A, Ekstr\u00f6m L. Recruitment to doping and help-seeking behavior of eight female AAS users. Subst Abuse Treat Prev Policy. 2016, 11:11. 10.1186\/s13011-016-0056-3","journal-title":"Subst Abuse Treat Prev Policy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/304271-abdominal-hypertrophy-syndrome-characteristics-and-potential-pathophysiology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T14:21:30Z","timestamp":1729520490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/304271-abdominal-hypertrophy-syndrome-characteristics-and-potential-pathophysiology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.72026","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,21]]}}}